MedPath

Evaluation of Neuroinflamation of SAH

Conditions
Subarachnoid Hemorrhage, Aneurysmal
Interventions
Diagnostic Test: Bezmialem VAkif Unv. Ethical board
Registration Number
NCT03822260
Lead Sponsor
Bezmialem Vakif University
Brief Summary

The investigators are planning that can these markers be used a predictive marker at SAH and for this aim we will study both patiens' blood sample and their CT image.

Detailed Description

An ideal marker which could be used clinically should meet numerous criteria, such as high sensitivity or the possibility of easy and quick assessment of its concentration in blood or blood plasma.The Fisher's scale presents an alternative for evaluating patients with subarachnoid hemorrhage . The investigator are going to evaluate both plasma markers and fishers scale at SAH.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Ruptured Subarachnoid Aneursym
Exclusion Criteria
  • without aneursymal sah
  • Patient's positive for rheumatoid factor and anti-CCP or with chronic inflammatory diseases (such as ankylosing spondylitis or rheumatoid arthritis), systemic diseases (such as hypercholesterolemia, hypertension, diabetes mellitus, myocardial infarction, stroke, peripheral artery disease), active infection, a history of term medication, trauma to the hip and smoking were excluded from the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Sur1/ Trpm 4 acitivities at SAHBezmialem VAkif Unv. Ethical boardonly after collecting sample,
Primary Outcome Measures
NameTimeMethod
Diagnostic marker identification24 months

Evaluation of the concentration levels of enflamation markers relation with Sur1 TRPM+ molecules, together with the values of global tests of coagulation system, may serve as a helpful SAH diagnostic marker.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath